Kokabi N - Search Results

1

Safety and Efficacy of Percutaneous Cholecystostomy for Emphysematous Cholecystitis.

Imanzadeh A, Kokabi N, Pourjabbar S, Latich I, Pollak J, Kim H, Gunabushanam G. Imanzadeh A, et al. Among authors: kokabi n. J Clin Imaging Sci. 2020 Mar 27;10:9. doi: 10.25259/JCIS_145_2019. eCollection 2020. J Clin Imaging Sci. 2020. PMID: 32257585 Free PMC article.

2

90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.

Xing M, Kokabi N, Camacho JC, Kooby DA, El-Rayes BF, Kim HS. Xing M, et al. Among authors: kokabi n. J Comp Eff Res. 2013 Jul;2(4):435-44. doi: 10.2217/cer.13.37. J Comp Eff Res. 2013. PMID: 24236684 Free article. Review.

3

Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.

Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS. Camacho JC, et al. Among authors: kokabi n. J Vasc Interv Radiol. 2014 Feb;25(2):256-65. doi: 10.1016/j.jvir.2013.10.056. J Vasc Interv Radiol. 2014. PMID: 24461131

4

A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS. Kokabi N, et al. J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007. J Vasc Interv Radiol. 2014. PMID: 24461133

5

Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.

Kokabi N, Camacho JC, Xing M, Qiu D, Kitajima H, Mittal PK, Kim HS. Kokabi N, et al. Abdom Imaging. 2014 Oct;39(5):969-78. doi: 10.1007/s00261-014-0127-8. Abdom Imaging. 2014. PMID: 24740759

6

Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.

Xing M, Kooby DA, El-Rayes BF, Kokabi N, Camacho JC, Kim HS. Xing M, et al. Among authors: kokabi n. J Surg Oncol. 2014 Aug;110(2):182-96. doi: 10.1002/jso.23619. Epub 2014 Apr 24. J Surg Oncol. 2014. PMID: 24760444 Review.

7

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.

Xing M, Prajapati HJ, Dhanasekaran R, Lawson DH, Kokabi N, Eaton BR, Kim HS. Xing M, et al. Among authors: kokabi n. Am J Clin Oncol. 2017 Feb;40(1):27-34. doi: 10.1097/COC.0000000000000109. Am J Clin Oncol. 2017. PMID: 25089529

8

PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.

Camacho JC, Kokabi N, Xing M, Schuster DM, Kim HS. Camacho JC, et al. Among authors: kokabi n. Clin Nucl Med. 2014 Nov;39(11):944-50. doi: 10.1097/RLU.0000000000000557. Clin Nucl Med. 2014. PMID: 25140563

9

Immediate post-doxorubicin drug-eluting beads chemoembolization Mr Apparent diffusion coefficient quantification predicts response in unresectable hepatocellular carcinoma: A pilot study.

Kokabi N, Camacho JC, Xing M, Edalat F, Mittal PK, Kim HS. Kokabi N, et al. J Magn Reson Imaging. 2015 Oct;42(4):981-9. doi: 10.1002/jmri.24845. Epub 2015 Feb 12. J Magn Reson Imaging. 2015. PMID: 25683022 Clinical Trial.

10

R.E.N.A.L. (Radius, exophytic/endophytic, nearness to collecting system or sinus, anterior/posterior, and location relative to polar lines) nephrometry score predicts early tumor recurrence and complications after percutaneous ablative therapies for renal cell carcinoma: a 5-year experience.

Camacho JC, Kokabi N, Xing M, Master VA, Pattaras JG, Mittal PK, Kim HS. Camacho JC, et al. Among authors: kokabi n. J Vasc Interv Radiol. 2015 May;26(5):686-93. doi: 10.1016/j.jvir.2015.01.008. Epub 2015 Mar 11. J Vasc Interv Radiol. 2015. PMID: 25769213

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page